21-22 April, 2027
Business Design Centre, London

CO₂ – The Master Regulator for Longevity

We delighted to introduce a speaker whose work invites us to rethink one of the most fundamental, yet often overlooked, regulators of human physiology.

Anders Olsson is the founder of the Conscious Breathing Institute in Stockholm and an internationally recognised expert on breathing physiology. For more than 15 years, he has explored how modern breathing patterns and low tolerance to carbon dioxide influence nervous system regulation, circulation, sleep quality, oxygen delivery, and overall resilience — mechanisms that sit at the core of healthy ageing.

An author and educator, Anders has trained more than 1,500 instructors worldwide and developed breathing and CO₂ therapy tools now used across medical, wellness, and performance settings. His work gained additional international attention through James Nestor’s bestselling book Breath, following a landmark breathing study conducted at Stanford University. As a speaker, he is widely respected for translating complex physiology into clear, practical insights that clinicians can apply within preventive and longevity-focused care.

At the 4th edition of the Longevity Med Summit 2026 in London, he presents:

“CO₂ – The Master Regulator for Longevity.”

In this session, Anders challenges the long-held perception of carbon dioxide as merely a metabolic byproduct, positioning it instead as a central regulator of breathing efficiency, blood flow, oxygen delivery, autonomic balance, sleep, and recovery. He will explore how low CO₂ tolerance may contribute to sympathetic dominance and reduced stress resilience, why low-intensity movement naturally supports CO₂ production, and what the slow, efficient breathing patterns observed in long-lived species may reveal about sustainable human physiology.

Bringing together physiology, clinical relevance, and evolutionary insight, this lecture offers a unifying perspective on carbon dioxide as a powerful, and underappreciated, lever in preventive and longevity medicine.

Please join us in warmly welcoming Anders Olsson to the Innovation stage.